Last reviewed · How we verify
NCT07186517: ÁRTEMIS-Brasil
Genetic Variants in Stroke
trial in Stroke in 1,000 participants. Not yet recruiting.
1 December 2030
Quick facts
| Lead sponsor | Hospital Moinhos de Vento |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 1 October 2025 |
| Primary completion | 1 December 2030 |
| Estimated completion | 31 December 2030 |
| Sites | 11 locations across Brazil |
Conditions studied
- Stroke — all drugs for Stroke →
- Genetic Association Studies — all drugs for Genetic Association Studies →
Sponsor
Hospital Moinhos de Vento
Who can join
18 and older, any sex, with Stroke or Genetic Association Studies. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Stroke is the leading cause of death and disability in Brazil and worldwide, with a significant socioeconomic impact. Despite advances in prevention and treatment, the role of genetic variants in ischemic stroke remains underexplored, especially in genetically diverse populations like Brazil's. International studies such as MEGASTROKE and GIGASTROKE have identified risk loci for stroke, but with low representation of the Latin American population. This study aims to fill that gap by evaluating the prevalence and clinical impact of genetic polymorphisms previously described in Brazilians, thereby laying the groundwork for precision medicine within Brazil's Unified Health System (SUS).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Verify or expand the search:
- PubMed search for NCT07186517
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other Hospital Moinhos de Vento trials
Trials by the same sponsor.
- NCT05996861 — Protocol For Sleep for Critically Ill Patients · unknown
- NCT05306600 — Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health System · recruiting
- NCT05572736 — Conduction System Pacing Versus Biventricular Resynchronization in Patients With Chronic Heart Failure · NA · completed
- NCT06903260 — Robot-assisted Partial Nephrectomy With and Without Mixed Reality (REALITATEM Study) · Phase 3 · completed
- NCT05403307 — A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07186517 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Moinhos de Vento
- Last refreshed: 22 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07186517.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing